As Of November 27, 2023, United Therapeutics Announced An Amendment Extending The Term Of Its Exclusive License Agreement With Eli Lilly Covering US Marketing, Promotion, And Sale Of Adcirca (Tadalafil) Tablets Through December 31, 2026 - 8K
Benzinga Newsdesk - Nov 29, 2023, 6:14AM